News


January 28, 2020

Arranta Bio announces key leadership additions of Chief Operations Officer and SVP of Business Development as it commits to a $100M investment in building end-to-end microbiome capacity

January 17, 2020

Alcami Expands its Sterile Fill-Finish Capacity with Acquisition of TriPharm Services

January 13, 2020

Interpace Biosciences Enters into Agreement for $20 Million Investment from 1315 Capital and Ampersand Capital Partners

December 16, 2019

Ampersand Capital Partners Acquires Peptides International And Merges Company With New England Peptide

December 4, 2019

Canopy Biosciences Acquires Core Diagnostics

November 13, 2019

Arranta Bio announces the acquisition of Captozyme™, creating a Center of Excellence for microbiome development and clinical supply

November 7, 2019

StageBio and Alizée Pathology Merge

October 31, 2019

Mesa Labs Acquires Gyros Protein Technologies

October 30, 2019

Arranta Bio announces $82M in new funding, and a strategic partnership with Thermo Fisher Scientific

October 17, 2019

Interpace Announces Closing of $13 Million Second Tranche Acquisition Financing from Ampersand Capital Partners